{"SPADE_UN_22222": {"Sequence Information": {"Peptide Name": "229E-HCoV-HR1P", "Sequence": "AASFNKAMTNIVDAFTGVNDAITQTSQALQTVATALNKIQDVVNQQGNSLNHLTSQ", "Sequence Length": 56, "Biological Activity": ["Antiviral", "Anticancer"], "Binding Target": "1. Virus entry", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "P15423", "uniprotUrl": "http://www.uniprot.org/uniprot/P15423", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that may represent a peptide precursor."}], "Literature": [{"Title": "A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike.", "Pubmed ID": "30989115", "Reference": "Sci Adv. 2019;5:eaav4580", "Author": "Xia S, et al.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30989115"}, {"Title": "Peptide-Based Membrane Fusion Inhibitors Targeting HCoV-229E Spike Protein HR1 and HR2 Domains.", "Pubmed ID": "29415501", "Reference": "Int J Mol Sci. 2018;19:E487", "Author": "Xia S, Xu W, Wang Q, Wang C, Hua C, Li W, Lu L, Jiang S", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29415501"}], "Mass": 5904.45, "PI": 5.3, "Net Charge": 0, "Hydrophobicity": -0.14, "Frequent Amino Acids": "ANQ", "Absent Amino Acids": "CEOPRUWY", "Basic Residues": 3, "Acidic Residues": 3, "Hydrophobic Residues": 23, "Polar Residues": 33, "Positive Residues": 3, "Negative Residues": 3, "SPADE ID": "SPADE_UN_22222", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_22225", "Similarity": 0.75, "Sequence": "AASFNKAINNIVASFSSVNDAITQTAEAIHTVTIALNKIQDVVNQQGSALNHLTSQ"}], "Hemolytic Activity": "", "Target Organism": "SARS-CoV(IC50 F=>5µM),MERS-CoV(IC50 F=>5µM),HCoV-229E(IC50 F=5.70µM),HCoV-NL63(IC50 F=>5µM),HCoV-OC43(IC50 F=>5µM),Vesicular Stomatitis Virus (VSV)(IC50 F=>10µM),HCoV-229E PsV(IC50 I=3.32µM),HCoV-229E(IC50 REP=13.24µM),HCoV-229E(IC50 REP=12.7µM),Human hepatocellular carcinoma Huh7(0-10% Cytotoxicity=1000µM),Human lung carcinoma A549(0-10% Cytotoxicity=1000µM)"}}}